Search for: "Dow Douglas" Results 1 - 20 of 65
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Apr 2024, 10:08 am by admin
The immunogenic mechanism had a few lines of potential support, with the most prominent at the time coming from the laboratories of Douglas Radford Shanklin, and his colleague, David L. [read post]
10 Feb 2023, 4:44 am by admin
Putting aside the idiosyncratic chapter by the late Professor Berger, most of the third edition of the Reference Manual presented guidance on many important issues. [read post]
12 May 2022, 2:17 am by Michael Douglas
Michael Douglas is Senior Lecturer at UWA Law School and a consultant in litigation at Bennett + Co, Perth. [read post]
12 Dec 2021, 2:22 pm by admin
The late Douglas Altman, who did so much to steer the medical literature toward greater validity, warned that dichotomizing continuous variables was known to cause loss of information, statistical power, and reliability in medical research.[17] In the field of pharmaco-epidemiology, the bias created by dichotomization of a continous variable is harmful from both the perspective of statistical estimation and hypothesis testing.[18] While readers are misled into believing that the study… [read post]
21 May 2021, 5:54 am
Evidence from Workplace Safety and Productivity Tradeoffs in the Coal Industry Posted by Erik Gilje (The Wharton School) and Michael Wittry (Ohio State University), on Wednesday, May 19, 2021 Tags: Agency costs, Decision making, Human capital, Information asymmetries, Management, Ownership structure, Private firms, Public firms, Risk Statement by Commissioner Peirce on S&P Dow Jones Indices LLC Posted by Hester M. [read post]
29 Mar 2021, 7:10 pm by admin
Some notes on vexing issue, which fortunately has never serious issue for me. [read post]
14 Jan 2021, 8:30 pm by Jim Sedor
Campaign Finance System Rocked as Major Firms Pause or Halt Political Contributions After Election Results Challenged Seattle Times – Todd Frankel, Jeff Stein, and Tony Romm (Washington Post) | Published: 1/11/2021 The funding of campaigns is being rocked as some of the nation’s biggest firms such as Facebook, Google, BlackRock, Marriott, and Dow announced plans to halt some or all political contributions as a result of the insurrection at the Capitol, a sign of… [read post]
18 Sep 2020, 1:10 am by Michael Douglas
Earlier in the year, Associate Professor Jeanne Huang reported on the Australian Information Commission’s action against Facebook Inc in the Federal Court of Australia. [read post]
13 Apr 2020, 4:19 pm by Kevin LaCroix
Nessim MezrahiIn the following guest post, Nessim Mezrahi discusses his analysis of the First Quarter 2020 securities class action lawsuit exposure. [read post]
16 Feb 2020, 9:38 am by Steve Lubet
The Dow Jones Industrial average fell over 20% and regulators had to confront new and complex issues relating to program trading and illiquidity in the markets. [read post]
1 Nov 2019, 8:00 am by ernst
Douglas, who had once served as the Chair of the SEC, dissented, noting presciently that the issues raised by the case were unlikely to go away.As civil rights history, SEC v. [read post]
2 Nov 2018, 7:32 pm by Schachtman
Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-12 (5th Cir. 1989) (“Fortunately, we do not have to resolve any of the above questions [as to bias and confounding], since the studies presented to us incorporate the possibility of these factors by the use of a confidence interval. [read post]
24 Oct 2017, 6:29 pm by Schachtman
Douglas Weed, similarly testified and elaborated on the concept of probability of causation and attributable risk.2 The plaintiffs’ counsel attempted to extricate themselves from this arithmetic quagmire by arguing that there was “multiple causation,” and interaction among causes. [read post]